Dr. Lal Pathlabs Limited — Call Transcript 2020

Jul 29, 2020

==> picture [24 x 42] intentionally omitted <==

==> picture [253 x 29] intentionally omitted <==

July 29, 2020

National Stock Exchange of India Limited Exchange Plaza, Plot No. C/1, G Block, Sandra Kurla Complex Sandra (E) Mumbai - 400 051.

Bombay Stock Exchange Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers Dalal Street Mumbai- 400001

Dear Sir/Madam,

Sub: Intimation of Conference Call for Investors/Analysts for Q1 FY 21

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the invite of the Conference Call for Investors/Analysts to be held on Friday, July 31, 2020 at 4:30 P.M. 1ST to discuss the financial and operating performance for Q1 FY 21.

We request you to please take the same on record.

Thanking You,

Yours Faithfully,

For Dr. Lal PathLabs Limited Rajat Kai Company Secretary and Legal Head

Encl: As above

==> picture [43 x 5] intentionally omitted <==

Regd. Oftice: Dr Lal Pathlabs Lta Si ·I.' E, Se.tor· 18. r 11,11. Nc.v Delhi - l I J085, ---C-o;pm.-.te Ofr:,e: Dr La, fd��L2::s Ltd l 2t" fJ, ., Tu,.er B. SAS Tc,.,·a: ' ',, fi. ity, Sert'lr-Jn. Gun;; am.

+91·11.3c; 3'., 'C, F"x: .,.9:. I 1-r : 2134 122 00 I. Haryana +91 · l 24-3C: 6-s,:� F,»·: +91-124.4;;:34. k

Conference Call Invitation

==> picture [209 x 72] intentionally omitted <==

Dr. Lal PathLabs’ Q1 FY21 Concall Invitation

Q1 FY21 Earnings Conference Call Friday, July 31, 2020 at 04:30 pm IST

Gurgaon, July 29, 2020:

Dr. Lal PathLabs Ltd. (DLPL) will be hosting a conference call to discuss its Q1 FY21 results. DLPL will be represented by (Hony) Brig. Dr. Arvind Lal – Executive Chairman, Dr. Om Prakash Manchanda – Managing Director, Mr. Bharath U – Chief Executive Officer and Mr. Ved Prakash Goel – Chief Financial Officer. We would also have Mr. Rajat Kalra - Company Secretary & Head of Investor Relations.

The conference call will be initiated with a brief discussion by the management on the Q1 FY21 financial and operating performance, which will be announced on the same day. Following this, there will be an opportunity for participants to get their queries addressed during the call.

Details of the conference call are as follows:

Time	04:30 pm IST on Friday, July 31, 2020
Pre-registration	To enable participants to connect to the conference call withouthaving to wait for an operator, please register at the belowmentioned link.You will receive dial in numbers, passcode and a pin for theconcall on the registered email address provided by you. Kindlydial into the call on the Conference Call date and use thepasscode &pin to connect to call.
Universal Access	+91 22 6280 1141+91 22 7115 8042
Local Access	**+91-7045671221 (**Available all over India)
	USA – 18667462133
Conference dial-in	UK – 08081011573
International Toll Number	Singapore – 8001012045
	Hong Kong – 800964448
Replay	+91 22 71945757 / +91 22 6663575728360 (passcode)Valid from July 31, 2020 to August 7, 2020

-ENDS-

Regd. Office: Dr. Lal PathLabs Ltd., Block E, Sector-I8, Rohini, New Delhi – 110085, Tel: +91-11 30258600. Fax: +91-11-2788-2134 Corporate Office: Or. Lal PathLabs Ltd., 12[th] Floor, Tower B, SAS Tower, Medicity, Sector-38, Gurugram - 122001, Haryana, Tel: +91-124-3016-500, Fax: +91-124-4234-468 E-mail: lalpathlabs@lalpathlabs.com, Web: www.lalpathlabs.com, CIN: L74899DL 1995PLC065388

About Dr. Lal PathLabs Limited (DLPL)

Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where patients and healthcare providers are offered a broad range of diagnostic and related healthcare tests and services for use in: core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. The services of DLPL are aimed at individual patients, hospitals and other healthcare providers and corporates.

As on March 31, 2020, DLPL’s has 216 clinical labs (including National Reference Lab at Delhi & Regional Reference Lab at Kolkata), 3,095 Patient Service Centers (PSCs) and 6,995 Pick-up Points (PUPs). In FY19 & FY20, DLPL collected and processed approximately 41.8 million samples and 47.7 million samples from approximately 17.6 million and 19.4 million patients, respectively.

Additional information on Dr. Lal PathLabs Limited: Corporate Identification No: L74899DL1995PLC065388 Website: https://www.lalpathlabs.com/

For further information please contact:

Ved Goel / Rajat Kalra Siddharth Rangnekar / Nishid Solanki Dr. Lal PathLabs Limited CDR India E-mail: ved.goel@lalpathlabs.com Email: siddharth@cdr-india.com rajat.kalra@lalpathlabs.com nishid@cdr-india.com

Regd. Office: Dr. Lal PathLabs Ltd., Block E, Sector-I8, Rohini, New Delhi – 110085, Tel: +91-11 30258600. Fax: +91-11-2788-2134 Corporate Office: Or. Lal PathLabs Ltd., 12[th] Floor, Tower B, SAS Tower, Medicity, Sector-38, Gurugram - 122001, Haryana, Tel: +91-124-3016-500, Fax: +91-124-4234-468 E-mail: lalpathlabs@lalpathlabs.com, Web: www.lalpathlabs.com, CIN: L74899DL 1995PLC065388